DE2322562C2 - Verfahren zur Bestimmung von Antigenen in einer Probe - Google Patents
Verfahren zur Bestimmung von Antigenen in einer ProbeInfo
- Publication number
- DE2322562C2 DE2322562C2 DE2322562A DE2322562A DE2322562C2 DE 2322562 C2 DE2322562 C2 DE 2322562C2 DE 2322562 A DE2322562 A DE 2322562A DE 2322562 A DE2322562 A DE 2322562A DE 2322562 C2 DE2322562 C2 DE 2322562C2
- Authority
- DE
- Germany
- Prior art keywords
- antibodies
- antigen
- bacterial
- bound
- polypeptide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 239000000427 antigen Substances 0.000 title claims description 46
- 102000036639 antigens Human genes 0.000 title claims description 46
- 108091007433 antigens Proteins 0.000 title claims description 46
- 238000000034 method Methods 0.000 title claims description 17
- 229920001184 polypeptide Polymers 0.000 claims description 34
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 34
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 34
- 230000001580 bacterial effect Effects 0.000 claims description 26
- 230000004520 agglutination Effects 0.000 claims description 19
- 239000002245 particle Substances 0.000 claims description 13
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 claims description 11
- 241000894006 Bacteria Species 0.000 claims description 10
- 238000006243 chemical reaction Methods 0.000 claims description 8
- 239000007788 liquid Substances 0.000 claims description 6
- 241000295644 Staphylococcaceae Species 0.000 claims description 5
- 241000191967 Staphylococcus aureus Species 0.000 claims description 4
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 claims description 3
- 230000008105 immune reaction Effects 0.000 claims description 3
- 241000191963 Staphylococcus epidermidis Species 0.000 claims description 2
- 150000001299 aldehydes Chemical class 0.000 claims description 2
- 230000009870 specific binding Effects 0.000 claims description 2
- 230000008447 perception Effects 0.000 claims 1
- 239000003153 chemical reaction reagent Substances 0.000 description 18
- 239000000243 solution Substances 0.000 description 9
- 239000000725 suspension Substances 0.000 description 9
- 230000027455 binding Effects 0.000 description 8
- 239000000463 material Substances 0.000 description 8
- 239000000523 sample Substances 0.000 description 7
- 102000011022 Chorionic Gonadotropin Human genes 0.000 description 6
- 108010062540 Chorionic Gonadotropin Proteins 0.000 description 6
- 102000004169 proteins and genes Human genes 0.000 description 6
- 108090000623 proteins and genes Proteins 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- 229940084986 human chorionic gonadotropin Drugs 0.000 description 5
- PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 230000001588 bifunctional effect Effects 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 239000002504 physiological saline solution Substances 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 3
- 241000700605 Viruses Species 0.000 description 3
- 239000000872 buffer Substances 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 239000012634 fragment Substances 0.000 description 3
- 241000283973 Oryctolagus cuniculus Species 0.000 description 2
- 239000010419 fine particle Substances 0.000 description 2
- 239000008098 formaldehyde solution Substances 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 239000011236 particulate material Substances 0.000 description 2
- 239000008363 phosphate buffer Substances 0.000 description 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 229910000162 sodium phosphate Inorganic materials 0.000 description 2
- 239000001488 sodium phosphate Substances 0.000 description 2
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 2
- 210000002700 urine Anatomy 0.000 description 2
- HKJKONMZMPUGHJ-UHFFFAOYSA-N 4-amino-5-hydroxy-3-[(4-nitrophenyl)diazenyl]-6-phenyldiazenylnaphthalene-2,7-disulfonic acid Chemical compound OS(=O)(=O)C1=CC2=CC(S(O)(=O)=O)=C(N=NC=3C=CC=CC=3)C(O)=C2C(N)=C1N=NC1=CC=C([N+]([O-])=O)C=C1 HKJKONMZMPUGHJ-UHFFFAOYSA-N 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 108060003951 Immunoglobulin Proteins 0.000 description 1
- 241000193996 Streptococcus pyogenes Species 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 229940098773 bovine serum albumin Drugs 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 229940015047 chorionic gonadotropin Drugs 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 239000012470 diluted sample Substances 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 1
- 108010074605 gamma-Globulins Proteins 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000003053 immunization Effects 0.000 description 1
- 230000000984 immunochemical effect Effects 0.000 description 1
- 102000018358 immunoglobulin Human genes 0.000 description 1
- 229940072221 immunoglobulins Drugs 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 125000000896 monocarboxylic acid group Chemical group 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 239000002953 phosphate buffered saline Substances 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000012460 protein solution Substances 0.000 description 1
- 239000012266 salt solution Substances 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000012085 test solution Substances 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/815—Test for named compound or class of compounds
- Y10S436/817—Steroids or hormones
- Y10S436/818—Human chorionic gonadotropin
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/828—Protein A
Landscapes
- Health & Medical Sciences (AREA)
- Immunology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Food Science & Technology (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE14328/72A SE368090B (en, 2012) | 1972-11-06 | 1972-11-06 | |
| SE7301777A SE7301777L (en, 2012) | 1973-02-08 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DE2322562A1 DE2322562A1 (de) | 1974-05-09 |
| DE2322562C2 true DE2322562C2 (de) | 1984-03-29 |
Family
ID=26655992
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE2322562A Expired DE2322562C2 (de) | 1972-11-06 | 1973-05-04 | Verfahren zur Bestimmung von Antigenen in einer Probe |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US4711841A (en, 2012) |
| JP (1) | JPS6161062B2 (en, 2012) |
| BE (1) | BE806715A (en, 2012) |
| CA (1) | CA1022459A (en, 2012) |
| CH (1) | CH596555A5 (en, 2012) |
| DE (1) | DE2322562C2 (en, 2012) |
| DK (1) | DK150810C (en, 2012) |
| FI (1) | FI55410C (en, 2012) |
| FR (1) | FR2206859A5 (en, 2012) |
| GB (1) | GB1406964A (en, 2012) |
| NL (1) | NL186657C (en, 2012) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE387746B (sv) * | 1974-05-29 | 1976-09-13 | Pharmacia Diagnostics Ab | Forfarande for visuellt pavisande av antikroppar i ett vattenhaltigt prov |
| US4189466A (en) | 1975-09-19 | 1980-02-19 | Technical Research Affiliates, Inc. | Detection of rheumatoid factor by antibody sensitized microbial particles |
| DE2644622C3 (de) * | 1976-10-02 | 1979-11-29 | Behringwerke Ag, 3550 Marburg | Extraktion von Mikroorganismen und diese enthaltende diagnostische Mittel |
| DE2643208C2 (de) * | 1976-09-25 | 1985-09-05 | Behringwerke Ag, 3550 Marburg | Immunologisches Bestimmungsverfahren |
| ES471585A1 (es) * | 1977-07-15 | 1979-01-16 | Behringwerke Ag | Procedimiento para la determinacion de reactivos fc |
| FR2420572A1 (en) * | 1978-03-24 | 1979-10-19 | Agronomique Inst Nat Rech | Reagent for diagnosis of staphylococcus aureus - prepd. by sensitisation of red blood cells with protein a reactive immunoglobulin(s), then treatment with glutaraldehyde and lyophilisation |
| JPS54139595A (en) * | 1978-04-20 | 1979-10-30 | Mitsubishi Chem Ind | Reagent for detecting antigen |
| US4292403A (en) | 1978-08-24 | 1981-09-29 | Akzona Incorporated | Detection and/or determination of IgM, IgA, IgD and IgE immunoglobulins |
| DE2941575A1 (de) * | 1978-10-19 | 1980-04-30 | Harvard College | Methode zur identifizierung einer virusinfektion und kit hierfuer |
| GB2051360B (en) * | 1979-01-18 | 1983-05-18 | Unilever Ltd | Processes and materials for detecting and determining proteinaceous specific binding agents and materials bindable thereto |
| US4230685A (en) * | 1979-02-28 | 1980-10-28 | Northwestern University | Method of magnetic separation of cells and the like, and microspheres for use therein |
| US4582793A (en) * | 1982-10-29 | 1986-04-15 | Research Corporation | Anti-RNA polymerase I antibody test for the diagnosis of rheumatological diseases |
| DK17885D0 (da) * | 1985-01-14 | 1985-01-14 | Karlsson Karl Anders | Antiviralt middel |
| JPS6348297A (ja) * | 1986-08-18 | 1988-02-29 | Sanraku Inc | Ｆｃ結合性蛋白質及びその生産菌 |
| SE8703453D0 (sv) * | 1987-09-04 | 1987-09-04 | Sven Kristofer Vilhelm Rubin | Preparation innehallande hogmolekylert bakteriellt protein, antikroppspreparation riktad deremot samt preparationernas anvendning |
| US5424193A (en) * | 1993-02-25 | 1995-06-13 | Quidel Corporation | Assays employing dyed microorganism labels |
| DE59606885D1 (de) * | 1996-12-18 | 2001-06-13 | Diagnostische Forsch Stiftung | Synthetische Partikel als Agglutinationsreagenzien |
| WO2002086120A1 (fr) * | 2001-04-20 | 2002-10-31 | Kansai Chemical Engineering Co., Ltd. | Proteine de liaison aux anticorps et d'expression de levure sur couche superficielle cellulaire et utilisation de ladite proteine |
| CN111458522B (zh) * | 2020-04-20 | 2024-01-09 | 杭州英邈生物科技有限公司 | 一种用于检测血浆白细胞介素6天然抗体的检测试剂、试剂盒及其应用 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL125235C (en, 2012) * | 1965-04-15 | |||
| US3639558A (en) * | 1968-02-19 | 1972-02-01 | Louis Csizmas | Immunological reagent particles having proteinaceous materials covalently bonded thereto |
| US3882225A (en) * | 1968-12-09 | 1975-05-06 | Miles Lab | Direct agglutination immunological reagent |
| JPS502730B1 (en, 2012) * | 1970-12-26 | 1975-01-29 | ||
| DE2322533C2 (de) * | 1972-11-06 | 1986-08-28 | Pharmacia AB, Uppsala | Verfahren zum Binden von Immunoglobulin und Hilfsmittel zur Durchführung des Verfahrens |
| US3966898A (en) * | 1973-06-28 | 1976-06-29 | Pharmacia Diagnostics Ab | Method and reagent for determining immunologic materials |
-
1973
- 1973-05-04 DE DE2322562A patent/DE2322562C2/de not_active Expired
- 1973-10-29 CA CA184,431A patent/CA1022459A/en not_active Expired
- 1973-10-30 BE BE137232A patent/BE806715A/xx not_active IP Right Cessation
- 1973-10-31 FI FI3373/73A patent/FI55410C/fi active
- 1973-11-02 DK DK593273A patent/DK150810C/da not_active IP Right Cessation
- 1973-11-05 CH CH1552873A patent/CH596555A5/xx not_active IP Right Cessation
- 1973-11-05 JP JP48124336A patent/JPS6161062B2/ja not_active Expired
- 1973-11-05 FR FR7339221A patent/FR2206859A5/fr not_active Expired
- 1973-11-06 GB GB5145973A patent/GB1406964A/en not_active Expired
- 1973-11-06 NL NLAANVRAGE7315184,A patent/NL186657C/xx not_active IP Right Cessation
-
1984
- 1984-10-10 US US06/659,424 patent/US4711841A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| FI55410B (fi) | 1979-03-30 |
| NL186657C (nl) | 1991-01-16 |
| JPS6161062B2 (en, 2012) | 1986-12-24 |
| CH596555A5 (en, 2012) | 1978-03-15 |
| DK150810B (da) | 1987-06-22 |
| DE2322562A1 (de) | 1974-05-09 |
| AU6172073A (en) | 1975-04-24 |
| GB1406964A (en) | 1975-09-17 |
| JPS49135691A (en, 2012) | 1974-12-27 |
| NL186657B (nl) | 1990-08-16 |
| BE806715A (fr) | 1974-04-30 |
| DK150810C (da) | 1988-03-28 |
| US4711841A (en) | 1987-12-08 |
| FR2206859A5 (en, 2012) | 1974-06-07 |
| CA1022459A (en) | 1977-12-13 |
| NL7315184A (en, 2012) | 1974-05-08 |
| FI55410C (fi) | 1979-07-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE2322562C2 (de) | Verfahren zur Bestimmung von Antigenen in einer Probe | |
| DE3884979T2 (de) | Agglutinationsimmunotest und Satz zur Bestimmung einer mehrwertigen Immunspezies unter Verwendung einer gepufferten Salzwasch-Lösung. | |
| DE2430357C2 (de) | Verfahren zur qualitativen oder quantitativen Feststellung von Immunoglobulin der IgG-Klasse | |
| DE68920140T2 (de) | Gerät und verfahren zur schnellen qualitativen und quantitativen bestimmung der anwesenheit eines reaktiven liganden in einer flüssigkeit. | |
| DE2743444C3 (de) | Immunchemisches Meßverfahren und Reagens zu seiner Durchführung | |
| DE3882058T2 (de) | Immunoreaktives Reagens, Verfahren zu seiner Herstellung und seine Verwendung zur Bestimmung einer immunoreaktiven Spezies. | |
| DE3136579A1 (de) | Analyse fuer thyroxin und 3, 5, 3'-trijodthyronin | |
| DE1648999C3 (de) | Verfahren zur immunochemischen Bestimmung von Antigenen und Antikörpern | |
| DE2551208B2 (de) | Verfahren zur Herstellung einer stabilen Erythrozyten-Präparation | |
| DE69106002T2 (de) | Testverfahren und reagenziensatz dafür. | |
| EP0001223A2 (de) | Mit einer Polyhydroxyverbindung beschichteten Latex, Verfahren zur Herstellung dieses Latex, immunologisches Reagenz enthaltend diesen Latex, Verfahren zur Herstellung dieses Reagenzes, Verwendung dieses Reagenzes, Bestimmungsverfahren unter Verwendung dieses Reagenzes und Reagenziengarnitur enthaltend dieses Reagenz. | |
| DE3117725A1 (de) | Verfahren zur bestimmung von mycobakterien und protein sowie fertigpack zu dessen durchfuehrung | |
| EP3438667B1 (de) | Bindungstest zur diagnose einer heparin-induzierten thrombozytopenie | |
| DE2134928B2 (de) | Immunologisches Reagens und Verfahren zu seiner Herstellung | |
| DE1961541A1 (de) | Immunologisches Indikatorreagens | |
| DE3022681C2 (en, 2012) | ||
| DE60035267T2 (de) | Verfahren zur analyse der menge an intraabdominalem fettgewebe | |
| DE2850950C3 (de) | Verwendung von nativem oder thermisch modifiziertem Cytochrom c als Stabilisator für ein immunochemisches Meßreagens, immunochemisches Meßreagens sowie Pufferlösung zur Probenverdünnung bei immunchemischen Meßverfahren | |
| WO2017109133A1 (de) | Verfahren zur in ovo geschlechterbestimmung von küken | |
| DE69922225T2 (de) | Cobalamintest | |
| CH646259A5 (de) | Diagnostisches mittel zur bestimmung eines antigens. | |
| DE3887727T2 (de) | Partikelstabilisierte Epitope zur Standardisierung und Kontrolle von Immuntests. | |
| CH636449A5 (de) | Verfahren zur gewinnung eines neuen, spezifischen alpha-l-antikoerpers. | |
| DE2023989B2 (de) | Verfahren zur Herstellung von aus Antigen Tragerstoffgemischen bestehenden und gegebenenfalls Antikörper enthalten den fertigen serodiagnostischen, auf einen Objektträger aufgebrachten lager bestandigen Testsubstanzen | |
| DE3883808T2 (de) | Testsatz, Extraktionsvorrichtung und Verfahren zur Bestimmung von Streptococcus-A-Antigen. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| OD | Request for examination | ||
| 8125 | Change of the main classification |
Ipc: G01N 33/54 |
|
| D2 | Grant after examination | ||
| 8364 | No opposition during term of opposition |